跳转至内容
Merck

G005890

HPLC Analysis of Paclitaxel and Related Compounds on Ascentis® Express F5

application for HPLC

登录查看公司和协议定价


About This Item

技術

HPLC: suitable

測試參數

column: Ascentis Express F5, 15 cm x 4.6 mm I.D., 5 μm particles (50631-U)
mobile phase: [A] water; [B] acetonitrile; (60:40, A:B)
flow rate: 1.5 mL/min
pressure: 2727 psi (188 bar)
column temp.: 30 °C
detector: UV, 227 nm
injection: 5 μL
sample: taxols 25 μg/mL in 70:15:15, water:methanol:acetonitrile

適合性

application for HPLC

應用

pharmaceutical (small molecule)

分析報告

An efficient reverse phase HPLC method for the HPLC analysis of of Paclitaxel (Taxol) and related compounds is developed using the Ascentis® Express F5 5μm Fused Core HPLC column. Paclitaxel is a natural product with antitumor activity. TAXOL (paclitaxel) is obtained via a semi-synthetic process from Taxus baccata.
The developed method can be easily used for the routine quality control of bulk and Parenterals dosage form of Paclitaxel within a short analysis time. This method offers the advantages of higher efficies, reduced backpressure and shorter run times over a traditionally run methods over 5 μm totally porous particle columns.

法律資訊

Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany

分析物

说明

    Baccatin III, ≥95% (HPLC)
    Cephalomannine, ≥97% (HPLC), solid
    Paclitaxel, from Taxus yannanensis, powder

从最新的版本中选择一种:

分析证书(COA)

Lot/Batch Number

抱歉,我们目前尚未线上提供该产品的COA。

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门